The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
POEMS Syndrome: 2019 Update on diagnosis, risk‐stratification, and management
Open accessAbstract
Disease Overview: Polyneuropathy, organomegaly, endocrinopathy, M‐protein, skin changes (POEMS) syndrome is a paraneoplastic syndrome due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyradiculoneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease. Minor features include organomegaly, endocrinopathy, characteristic skin changes, papilledema, extravascular volume overload, and thrombocytosis. Diagnoses are often delayed because the syndrome is rare and can be mistaken for other neurologic disorders, most commonly chronic inflammatory demyelinating polyradiculoneuropathy. POEMS syndrome should be distinguished from the Castleman disease variant of POEMS syndrome, which has no clonal PCD and typically little to no peripheral neuropathy but has several of the minor diagnostic criteria for POEMS syndrome. Diagnosis: The diagnosis of POEMS syndrome is made with three of the major criteria, two of which must include polyradiculoneuropathy and clonal PCD, and at least one of the minor criteria. Risk Stratification: Because the pathogenesis of the syndrome is not well understood, risk stratification is limited to clinical phenotype rather than specific molecular markers. Risk factors include low serum albumin, age, pleural effusion, pulmonary hypertension, and reduced eGFR. Risk‐Adapted Therapy: For those patients with a dominant sclerotic plasmacytoma, first line therapy is irradiation. Patients with diffuse sclerotic lesions or disseminated bone marrow involvement and for those who have progression of their disease 3 to 6 months after completing radiation therapy should receive systemic therapy. Corticosteroids are temporizing, but alkylators are the mainstay of treatment, either in the form of low dose conventional therapy or high dose with stem cell transplantation. Lenalidomide shows promise with manageable toxicity. Thalidomide and bortezomib also have activity, but their benefit needs to be weighed against their risk of exacerbating the peripheral neuropathy. Prompt recognition and institution of both supportive care measures and therapy directed against the plasma cell result in the best outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
POEMS syndrome: definitions and long-term outcome
Dispenzieri, A., Kyle, R. A., Lacy, M. Q., Rajkumar, S. V., Therneau, T. M., Larson, D. R., Greipp, P. R., Witzig, T. E., Basu, R., Suarez, G. A., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2299 · Cited by 820
Self-citationBARDWICK, P. A., ZVAIFLER, N. J., GILL, G. N., NEWMAN, D., GREENWAY, G. D., & RESNICK, D. L. (1980) · Medicine · doi:10.1097/00005792-198007000-00006 · Cited by 699
The Crow‐Fukase syndrome: A study of 102 cases in Japan
Nakanishi, T., Sobue, I., Toyokura, Y., Nishitani, H., Kuroiwa, Y., Satoyoshi, E., Tsubaki, T., Igata, A., & Ozaki, Y. (1984) · Neurology · doi:10.1212/wnl.34.6.712 · Cited by 553
Multicentric angiofollicular lymph node hyperplasia: A clinicopathologic study of 16 cases
Weisenburger, D. D., Nathwani, B. N., Winberg, C. D., & Rappaport, H. (1985) · Human Pathology · doi:10.1016/s0046-8177(85)80065-4 · Cited by 376
Multicentric Giant Lymph Node Hyperplasia
Gaba, A. R., Stein, R. S., Sweet, D. L., & Variakojis, D. (1978) · American Journal of Clinical Pathology · doi:10.1093/ajcp/69.1.86 · Cited by 359
POEMS syndrome: A study of 25 cases and a review of the literature
Soubrier, M., Dubost, J., & Sauvezie, B. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90350-6 · Cited by 342
Dispenzieri, A. (2007) · Blood Reviews · doi:10.1016/j.blre.2007.07.004 · Cited by 311
Self-citationPolyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis
Scarlato, M., Previtali, S. C., Carpo, M., Pareyson, D., Briani, C., Del Bo, R., Nobile-Orazio, E., Quattrini, A., & Comi, G. P. (2005) · Brain · doi:10.1093/brain/awh519 · Cited by 241
Dispenzieri, A., Moreno-Aspitia, A., Suarez, G. A., Lacy, M. Q., Colon-Otero, G., Tefferi, A., Litzow, M. R., Roy, V., Hogan, W. J., Kyle, R. A., et al. (2004) · Blood · doi:10.1182/blood-2004-05-2046 · Cited by 206
Self-citationMass Spectrometry–Based Proteomic Diagnosis of Renal Immunoglobulin Heavy Chain Amyloidosis
Sethi, S. M., Theis, J. D., Leung, N., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02890310 · Cited by 136
Bélec, L., Si‐Mohamed, A., Authier, F., Hallouin, M., Soe, A. M., Cotigny, S., Gaulard, P., & Gherardi, R. K. (1999) · Blood · doi:10.1182/blood.v93.11.3643 · Cited by 135
Dispenzieri, A. A., Lacy, M. Q., Hayman, S. R., Kumar, S. K., Buadi, F. K., Dingli, D., Litzow, M. R., Gastineau, D. A., Inwards, D. J., Elliott, M. A., et al. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01037.x · Cited by 128
Self-citationDao, L. N., Hanson, C. A., Dispenzieri, A. A., Morice, W. G., Kurtin, P. J., & Hoyer, J. D. (2011) · Blood · doi:10.1182/blood-2010-11-316935 · Cited by 125
Self-citationEndocrinopathy in POEMS Syndrome: The Mayo Clinic Experience
Gandhi, G. Y., Basu, R., Dispenzieri, A. A., Basu, A., Montori, V. M., & BRENNAN, M. D. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.7.836 · Cited by 118
Self-citationNishi, J.-I., Arimura, K., Utsunomiya, A., Yonezawa, S., Kawakami, K., Maeno, N., Ijichi, O., Ikarimoto, N., Nakata, M., Kitajima, I., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01208.x · Cited by 109
Lenalidomide therapy in a patient with POEMS syndrome
Dispenzieri, A. A., Klein, C. J., & Mauermann, M. L. (2007) · Blood · doi:10.1182/blood-2007-03-082354 · Cited by 104
Self-citationMenke, D. M., Tiemann, M., Camoriano, J. K., Chang, S.-F., Madan, A., Chow, M., Habermann, T. M., & Parwaresch, R. M. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/105.3.268 · Cited by 103
Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome
Kanai, K., Sawai, S., Sogawa, K., Mori, M., Misawa, S., Shibuya, K., Isose, S., Fujimaki, Y., Noto, Y., Sekiguchi, Y., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318263c42b · Cited by 101
Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome
Kuwabara, S., Misawa, S., Kanai, K., Sawai, S., Hattori, T., Nishimura, M., & Nakaseko, C. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.150177 · Cited by 95
Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome
Koike, H., Iijima, M., Mori, K., Yamamoto, M., Hattori, N., Watanabe, H., Tanaka, F., Doyu, M., & Sobue, G. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.135681 · Cited by 94
Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome
Wang, C., Huang, X.-F., Cai, Q.-Q., Xx, C., Duan, M.-H., Cai, H., Zhou, D.-B., & Li, J. (2016) · Leukemia · doi:10.1038/leu.2016.168 · Cited by 89
Misawa, S., Sato, Y., Katayama, K., Nagashima, K., Aoyagi, R., Sekiguchi, Y., Sobue, G., Koike, H., Yabe, I., Sasaki, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30157-0 · Cited by 78
Li, J., Huang, X., Cai, Q., Wang, C., Cai, H., Zhao, H., Zhang, L., Cao, X., Gale, R. P., & Zhou, D. (2018) · American Journal of Hematology · doi:10.1002/ajh.25100 · Cited by 76
Dm, M., Camoriano, J. K., & Pm, B. (1992) · PubMed · Cited by 72
Xu, J., Wang, Q., Xu, H., Gu, C., Jiang, L., Wang, J., Wang, D., Xu, B., Mao, X., Wang, J., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0672-7 · Cited by 70
Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis
Zagouri, F., Kastritis, E., Gavriatopoulou, M., Sergentanis, T. Ν., Ψαλτοπούλου, Θ., Terpos, E., & Dimopoulos, M. A. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.869329 · Cited by 66
Skin Manifestations and Vascular Endothelial Growth Factor Levels in POEMS Syndrome
Barète, S., Mouawad, R., Choquet, S., Viala, K., Leblond, V., Musset, L., Amoura, Z., Khayat, D., & Francès, C. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.100 · Cited by 66
Zhao, H., Huang, X., Gao, X., Cai, H., Zhang, L., Feng, J., Cao, X., Zhou, D., & Li, J. (2019) · Leukemia · doi:10.1038/s41375-019-0391-2 · Cited by 66
POEMS syndrome presenting as systemic sclerosis
Viard, J., Lesavre, P., Boîtard, C., Noël, L., Roth, A., Saïd, G., & Bach, J. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90277-x · Cited by 64
Poems syndrome with idiopathic flushing mimicking carcinoid syndrome
Myers, B. M., Miralles, G. D., Taylor, C. A., et al. (1991) · The American Journal of Medicine · doi:10.1016/s0002-9343(05)80020-8 · Cited by 58
The skin changes of POEMS syndrome
Ishikawa, O., Nihei, Y., & Ishikawa, H. (1987) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1987.tb04933.x · Cited by 57
Bortezomib: a new therapeutic option for POEMS syndrome
Kaygusuz, I., Tezcan, H., Çeti̇ner, M., Kocakaya, O., Uzay, A., & Bayık, M. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01341.x · Cited by 55
Wang, C., Huang, X., Cai, Q.-Q., Cao, X., Cai, H., Zhou, D., & Li, J. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.09.017 · Cited by 49
Endo, I., Mitsui, T., Nishino, M., Oshima, Y., & Matsumoto, T. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.1196 · Cited by 45
Genetic and transcriptional landscape of plasma cells in POEMS syndrome
Nagao, Y., Mimura, N., Takeda, J., Yoshida, K., Shiozawa, Y., Oshima, M., Aoyama, K., Saraya, A., Koide, S., Rizq, O., et al. (2019) · Leukemia · doi:10.1038/s41375-018-0348-x · Cited by 42
Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias
Briani, C., Fabrizi, G. M., Ruggero, S., Torre, C. D., Ferrarini, M., Campagnolo, M., Cavallaro, T., Ferrari, S., Scarlato, M., Taioli, F., et al. (2010) · Muscle & Nerve · doi:10.1002/mus.21872 · Cited by 40
Castleman Disease in Association With POEMS
Adelman, H. M., Cacciatore, M., Pascual, J. F. R., et al. (1994) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199402000-00008 · Cited by 39
Mineta, M., Hatori, M., Sano, H., Hosaka, M., Kokubun, S., Hiroki, E., Hatakeyama, A., & Ogasawara, T. (2006) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.210.269 · Cited by 35
Severe polyneuropathy: Initial manifestation of Castleman's disease associated with POEMS syndrome
Ku, A., Lachmann, E. A., Tunkel, R. S., et al. (1995) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(95)80643-1 · Cited by 34
Prevalence and Course of Endocrinopathy in POEMS Syndrome
Caimari, F., Keddie, S., Lunn, M. P., D’Sa, S., & Baldeweg, S. E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01516 · Cited by 31
Daratumumab for POEMS Syndrome
Khan, M., Stone, K., & van Rhee, F. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.02.001 · Cited by 29
Zeng, K., Yang, J., Li, J., Wei, Q., Yang, Y.-M., Liu, T., & Niu, T. (2012) · Acta Haematologica · doi:10.1159/000343681 · Cited by 28
Nakazawa, K., Itoh, N., Shigematsu, H., & Koh, C. (1992) · Acta Pathologica Japonica · doi:10.1111/j.1440-1827.1992.tb03046.x · Cited by 28
Kojima, H., Katsuoka, Y., Katsura, Y., Suzuki, S., Suzukawa, K., Hasegawa, Y., & Nagasawa, T. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06067 · Cited by 24
Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome
Wang, C., Su, W., Zhang, W. Y., Di, Q., Duan, M., Ji, W., Cao, X., Zhou, D., & Li, J. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2019-y · Cited by 24
[Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome].
Arimura, K. (1999) · PubMed · Cited by 24
Buxhofer‐Ausch, V., Gisslinger, B., Stangl, G., Rauschka, H., & Gisslinger, H. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.01.018 · Cited by 18
Prevalence and risk factors for depression in newly diagnosed patients with POEMS syndrome
Zhang, L., Zhou, Y.-L., Zhang, W., Duan, M., Cao, X., Zhou, D., & Li, J. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.893309 · Cited by 12
Cited by
Dispenzieri, A., & Fajgenbaum, D. C. (2020) · Blood · doi:10.1182/blood.2019000931 · Cited by 487
Self-citation
Metadata
- Authors
- Dispenzieri, A.
- Venue
- American Journal of Hematology
- Publisher
- Wiley
- Published
- 2019-05-23
- Volume
- 94
- Issue
- 7
- Pages
- 812-827
- ISSN
- 0361-8609 (ISSN-L)
- 1096-8652
- OpenAlex
- W2946259664
- Cited by
- 286
- References
- 48
- FWCI
- 23.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.